Following transfection and subsequent expression of cystatin M/E, the growth of RCC cell lines was compromised, supporting the status of cystatin M/E as a candidate kidney tumor suppressor [112] (summarized in Table 2). This evidence concerns the gene CST6 and renal cell carcinoma.